113 related articles for article (PubMed ID: 35279624)
1. Post-aggression suicide under the influence of new psychoactive substances AMB-FUBINACA and U-47700.
Romańczuk A; Rojek S; Kula K; Maciów-Głąb M; Synowiec K; Moskała A; Rzepecka-Woźniak E; Kłys M
Leg Med (Tokyo); 2022 May; 56():102053. PubMed ID: 35279624
[TBL] [Abstract][Full Text] [Related]
2. Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.
Adamowicz P; Meissner E; Maślanka M
Clin Toxicol (Phila); 2019 Nov; 57(11):1103-1108. PubMed ID: 30806094
[No Abstract] [Full Text] [Related]
3. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
[TBL] [Abstract][Full Text] [Related]
4. Determine the pharmacokinetics (half-life, volume of distribution and clearance) of AMB-FUBINACA in rats plasma using GC-MS / MS.
Abdelgadir EH; Alshehri SD; Kumar S
J Pharmacol Toxicol Methods; 2024; 127():107513. PubMed ID: 38729531
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
6. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R
N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
8. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
[TBL] [Abstract][Full Text] [Related]
9. The phenomenon of para-Fluorophenylpiperazine (pFPP) in combination with the synthetic cannabinoid AMB-FUBINACA in seized plant material in New Zealand.
Johnson CS; Stansfield CR; Hassan VR; Kolbe E; Partington HK; Kappatos DC; Somerville RF
Forensic Sci Int; 2020 Feb; 307():110107. PubMed ID: 31951949
[TBL] [Abstract][Full Text] [Related]
10. Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.
Oliveira da Cruz JF; Ioannidou C; Pagano Zottola AC; Muguruza C; Gomez-Sotres P; Fernandez M; Callado LF; Marsicano G; Busquets-Garcia A
Addict Biol; 2021 May; 26(3):e12940. PubMed ID: 32744799
[TBL] [Abstract][Full Text] [Related]
11. Quantification of U-47700 and its metabolites in plasma by LC-MS/MS.
Smith CR; Truver MT; Swortwood MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():41-47. PubMed ID: 30849683
[TBL] [Abstract][Full Text] [Related]
12. Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - Potential impact on therapeutic decisions.
Franz F; Haschimi B; King LA; Auwärter V
Drug Test Anal; 2020 Mar; 12(3):391-396. PubMed ID: 31944614
[TBL] [Abstract][Full Text] [Related]
13. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism.
Finlay DB; Mackie W; Webb HDJ; Thomsen LR; Nimick M; Rosengren RJ; Marusich JA; Glass M; Wiley JL
Pharmacol Biochem Behav; 2023 Feb; 223():173530. PubMed ID: 36805861
[TBL] [Abstract][Full Text] [Related]
14. Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MS.
Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
Biomed Chromatogr; 2020 Sep; 34(9):e4884. PubMed ID: 32415732
[TBL] [Abstract][Full Text] [Related]
15. Application of a simultaneous screening method for the detection of new psychoactive substances in various matrix samples using liquid chromatography/electrospray ionization tandem mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
Kim NS; Lim NY; Choi HS; Lee JH; Kim H; Baek SY
Rapid Commun Mass Spectrom; 2021 May; 35(10):e9067. PubMed ID: 33656207
[TBL] [Abstract][Full Text] [Related]
16. Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.
Finlay DB; Manning JJ; Ibsen MS; Macdonald CE; Patel M; Javitch JA; Banister SD; Glass M
ACS Chem Neurosci; 2019 Oct; 10(10):4350-4360. PubMed ID: 31513380
[TBL] [Abstract][Full Text] [Related]
17. In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats.
Fabregat-Safont D; Mata-Pesquera M; Barneo-Muñoz M; Martinez-Garcia F; Mardal M; Davidsen AB; Sancho JV; Hernández F; Ibáñez M
Commun Biol; 2022 Feb; 5(1):161. PubMed ID: 35210552
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
[TBL] [Abstract][Full Text] [Related]
19. Aspects related to analysis and medico-legal assessment in the context of the presence of synthetic cannabinoids in biological material based on the example of AB-CHMINACA.
Romańczuk A; Rojek S; Kula K; Kłys M
Arch Med Sadowej Kryminol; 2018; 68(4):266-280. PubMed ID: 31025844
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
